StockStory favors Globus Medical (GMED), flags Privia (PRVA) and Collegium (COLL) in health care screen

StockStory on May 13, 2026, highlighted Globus Medical (NYSE: GMED) as its preferred health care stock while taking a cautious view on Privia Health (NASDAQ: PRVA) and Collegium Pharmaceutical (NASDAQ: COLL), citing mixed sector performance and valuation concerns. Health care stocks have gained 3.7% over the past six months, trailing the S&P 500’s 7.1% rise, as post-COVID inventory destocking and slower growth weigh on returns. Globus Medical, valued at $10.58 billion, traded at $78.81, or 17.8 times forward earnings. The company develops spine, orthopedic and neurosurgical devices and operates in 64 countries. Privia Health, with a $2.91 billion market value, traded at $23.05, or 22.4 times forward earnings. Collegium Pharmaceutical, valued at $1.23 billion, traded at $37.78, implying 1.8 times forward price-to-sales. StockStory said both stocks warranted caution but did not provide detailed financial metrics in the article.